UK COVID Vaccine Maker To Buy French Pharma Biz For $16M
Oxford Biomedica PLC said Wednesday it is in talks with Institut Merieux over the purchase of the French holding company's gene-based vaccine manufacturing firm, ABL Europe, for €15 million ($16 million)....To view the full article, register now.
Already a subscriber? Click here to view full article